Company & Sponsor Intelligence
University of Milano Bicocca
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting2
Completed2
Countries1
Therapeutic footprint
alzheimersepilepsyschizophrenia
Indexed studies
NCT04694482The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology
schizophrenia · ItalyCOMPLETED
schizophrenia · ItalyCOMPLETED
NCT05756621Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest
epilepsy · ItalyCOMPLETED
epilepsy · ItalyCOMPLETED
NCT07457138Lombard Cohort of Brain Health Services
alzheimers · ItalyRECRUITING
alzheimers · ItalyRECRUITING
NCT07479914Art of Memory for Cognitive Enhancement in the Monza Brain Health Service
alzheimers · ItalyNA
alzheimers · ItalyNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →